<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Some drugs and substances that can increase heat-related morbidity</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Some drugs and substances that can increase heat-related morbidity</h1>
<div class="graphic"><div class="figure"><div class="ttl">Some drugs and substances that can increase heat-related morbidity</div><div class="cntnt"><table cellspacing="0"><colgroup span="2" width="50%"></colgroup> <tbody> <tr> <td class="subtitle1">Class</td> <td class="subtitle1">Mechanism</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Analgesics</td> </tr> <tr> <td class="indent1"> <ul> <li>NSAIDs</li> </ul> </td> <td>Acute kidney injury particularly in older adults and patients who are dehydrated</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Anticholinergics</td> </tr> <tr> <td class="indent1"> <ul> <li>Atropine</li> <li>Hyoscyamine</li> <li>Scopolamine</li> <li>Other anticholinergics<sup>*</sup> (also refer to other classes with anticholinergic effects)</li> </ul> </td> <td>Centrally impaired thermoregulation, impaired sweating, hypotension, reduced cardiac output, sedation, cognitive impairment</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antihistamines H1 (first-generation) and antivertigo antiemetics</td> </tr> <tr> <td class="indent1"> <ul> <li>Diphenhydramine</li> <li>Hydroxyzine</li> <li>Meclizine</li> <li>Promethazine</li> <li>Other first generation H1 antihistamines</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, sedation</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antiparkinson</td> </tr> <tr> <td class="indent1"> <ul> <li>Benztropine</li> <li>Trihexyphenidyl</li> <li>Procyclidine</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, cognitive impairment</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Antiseizure medications</td> </tr> <tr> <td class="indent1"> <ul> <li>Carbamazepine</li> <li>Oxcarbazepine</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, sedation, cognitive impairment</td> </tr> <tr> <td class="indent1"> <ul> <li>Topiramate</li> <li>Zonisamide</li> </ul> </td> <td>Carbonic anhydrase inhibition, impaired sweating</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Bladder antispasmodics (also known as antimuscarinics)</td> </tr> <tr> <td class="indent1"> <ul> <li>Darifenacin</li> <li>Oxybutynin</li> <li>Solifenacin</li> <li>Tolterodine</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, cognitive impairment</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Cardiovascular</td> </tr> <tr> <td class="indent1"> <ul> <li>Antihypertensives (RASIs [eg, ACEIs, ARBs] beta blockers, clonidine)</li> </ul> </td> <td> <p>Syncope, hypotension (particularly new start RASI in combination with a diuretic), altered peripheral vascular response</p> (Clonidine by central adrenergic effect)</td> </tr> <tr> <td class="indent1"> <ul> <li>Diuretics</li> </ul> </td> <td>Diuresis, hypovolemia, dehydration, syncope, reduced thirst sensation, altered peripheral vascular response, electrolyte derangements, acute kidney injury</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Muscle relaxants</td> </tr> <tr> <td class="indent1"> <ul> <li>Carisoprodol</li> <li>Orphenadrine</li> <li>Tizanidine</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, sedation, cognitive impairment</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Psychotropic</td> </tr> <tr> <td class="indent1"> <ul> <li>Antipsychotics<sup>*</sup></li> </ul> </td> <td>Centrally impaired thermoregulation, impaired sweating, hypotension, reduced cardiac output</td> </tr> <tr> <td class="indent1"> <ul> <li>SSRIs/SNRIs</li> </ul> </td> <td>Increased sweating promoting dehydration, electrolyte derangements (eg, hyponatremia)</td> </tr> <tr> <td class="indent1"> <ul> <li>CNS stimulants (eg, amphetamines)</li> </ul> </td> <td>Centrally impaired thermoregulation, increased higher core temperature, vasoconstriction, impaired perception of fatigue/exertion</td> </tr> <tr> <td class="indent1"> <ul> <li>Tricyclic antidepressants</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating<sup>¶</sup>, hypotension, reduced cardiac output</td> </tr> <tr> <td class="indent1"> <ul> <li>MAOIs</li> </ul> </td> <td>Anticholinergic effects<sup>*</sup>, impaired sweating, increased metabolism</td> </tr> <tr> <td class="subtitle2_left" colspan="2">Substances of misuse</td> </tr> <tr> <td class="indent1"> <ul> <li>Alcohol</li> </ul> </td> <td> <p>Increased sweating, diuresis</p> Impaired heat and thirst perception</td> </tr> <tr> <td class="indent1"> <ul> <li>Cocaine</li> </ul> </td> <td> <p>Impaired sweating and cutaneous vasodilation</p> Impaired heat perception</td> </tr> <tr> <td class="indent1"> <ul> <li>MDMA (ecstasy)</li> </ul> </td> <td>Reduced sweating, impaired vasodilation, impaired heat perceptions</td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>ACEI: angiotensin-converting enzyme inhibitor; 
        ARB: angiotensin receptor blocker; 
        CNS: central nervous system; 
        M3R: muscarinic acetylcholine receptor M3; 
        MAOI: monoamine oxidase inhibitor; 
        MDMA: methylenedioxymethamphetamine; 
        NSAIDs: nonsteroidal antiinflammatory drugs; 
        RASi: renin angiotensin system inhibitor; 
        SNRI: serotonin-norepinephrine reuptake inhibitors; 
        SSRI: selective serotonin reuptake inhibitors.</p>
<p>Medications and other substances can increase risk of heat-related illness through a range of mechanisms. Advanced age, comorbidity, organ impairment, and environmental factors can further increase risk. Comparative risk within each class can vary by specific agent or may not be well distinguished<sup>[1]</sup>. Clinicians should consider the effects of other medications or substances of abuse not listed above with sedative effects or that cause cognitive impairment (eg, opioids, benzodiazepines, other antiseizure drugs); such medications impair alertness, perception of hot weather, and judgment. Some substances of abuse such as sympathomimetics increase heat generation through neuromuscular activity.</p>
    
    Patients who are dehydrated are at increased risk of toxicities due to reduced kidney clearance of drugs, electrolyte derangements, and acute kidney injury. For additional information, refer to UpToDate topics on heat illness including nonexertional hyperthermia and climate emergencies.</div><div class="graphic_footnotes"><p>* Anticholinergic drugs exert variable effects on CNS thermal regulation and cognitive function as well as peripheral sweat production through M3 sub-receptor antagonism; effect(s) vary depending on the receptor affinity of the drug, the extent to which it penetrates CNS, dose, and route of administration<sup>[2,3]</sup>. Refer to separately available table of anticholinergic activity of medications. Those labeled "high" are more likely to impair physiologic heat adaptation.</p>
    
    ¶ Tricyclic antidepressants can increase sweating in some individuals thereby contributing to <span class="nowrap_whitespace">dehydration<sup>[2]</sup>.</span></div><div class="graphic_reference">References:
    <ol>
<li>Martin-Latry K, Goumy MP, Latry P. Psychotropic drugs use and risk of heat-related hospitalisation. Eur Psychiatry 2007; 22:335.</li>
<li>Cheshire WP, Fealey RD. Drug-induced hyperhidrosis and hypohidrosis: incidence, prevention and management. Drug Saf 2008; 31:109.</li>
<li>Westaway K, Frank O, Husband A, et al. Medicines can affect thermoregulation and accentuate the risk of dehydration and heat-related illness during hot weather. J Clin Pharm Ther 2015; 40:363.</li>
</ol></div><div id="graphicVersion">Graphic 141961 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
